Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Banco Santander ADR (SAN)

Banco Santander ADR (SAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,773,116
  • Shares Outstanding, K 17,340,640
  • Annual Sales, $ 66,283 M
  • Annual Income, $ -10,019 M
  • 60-Month Beta 1.33
  • Price/Sales 1.25
  • Price/Cash Flow 7.80
  • Price/Book 0.54
Trade SAN with:
  • Price/Earnings ttm 8.90
  • Earnings Per Share ttm 0.41
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.083 on 10/30/19
  • Sectors:

    SIC-6029 Commercial Banks, NEC

    Banks - Foreign

Options Overview

Details
  • Implied Volatility 30.67%
  • Historical Volatility 33.12%
  • IV Percentile 8%
  • IV Rank 7.88%
  • IV High 128.24% on 03/29/21
  • IV Low 22.32% on 03/26/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 447
  • Volume Avg (30-Day) 1,445
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 285,439
  • Open Int (30-Day) 288,710

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.09
  • Growth Rate Est. (year over year) +1,109,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.40 +8.53%
on 07/20/21
4.06 -9.11%
on 06/25/21
-0.26 (-6.58%)
since 06/23/21
3-Month
3.40 +8.53%
on 07/20/21
4.38 -15.75%
on 06/09/21
+0.26 (+7.58%)
since 04/23/21
52-Week
1.78 +107.30%
on 09/24/20
4.38 -15.75%
on 06/09/21
+1.29 (+53.75%)
since 07/23/20

Most Recent Stories

More News
Santander US Joins Financial Literacy for All as a National Member Company

Santander Holdings USA, Inc. ("Santander US" and "Santander") announced today that it has become a national member company of Financial Literacy for All - a consortium of US companies and leaders from...

SAN : 3.69 (+1.93%)
SC : 40.86 (+0.15%)
Lloyds (LYG) to Shut 44 Branches as Clients Shift to Digital Banking

Lloyds' (LYG) plan to close additional 44 branches stems from the customers' preference for digital banking.

ING : 12.37 (+0.65%)
LYG : 2.47 (+2.07%)
SAN : 3.69 (+1.93%)
HSBC : 27.64 (+0.44%)
Increasing Prevalence of Acute Otitis Media to Drive Acute Otitis Media Therapeutics Market Growth

Research Nester released a report titled which delivers detailed overview of the global acute otitis media therapeutics market in terms of market segmentation by drug type, formulation, distribution channel...

BAYRY : 15.0100 (+0.07%)
NVS : 91.65 (+0.63%)
PDP.VN : 0.300 (+1.69%)
PFE : 41.75 (+0.68%)
BAYN : 0.0100 (unch)
NOVN : 8.36 (-2.90%)
LLY : 243.87 (+2.26%)
GSK : 39.55 (+0.82%)
MDP : 42.23 (+1.37%)
SAN : 3.69 (+1.93%)
ABT : 120.86 (+2.21%)
Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

, /PRNewswire/ -- Sanofi is partnering with leading groups delivering practice-changing breast cancer research, the Breast International Group (BIG), the European Organization for Research and Treatment...

SAN : 3.69 (+1.93%)
SNY : 51.96 (+1.05%)
Sanofi and Merck's first and only six-in-one pediatric combination vaccine now available in the United States

and , /PRNewswire/ -- Vaxelis™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed as part of a partnership...

MRK : 77.56 (+1.35%)
SAN : 3.69 (+1.93%)
SNY : 51.96 (+1.05%)
Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology research

and , /PRNewswire/ --Sanofi has entered into a three-year research collaboration with School of Medicine. Together, the two organizations and their scientists will work to advance the understanding of...

SAN : 3.69 (+1.93%)
SNY : 51.96 (+1.05%)
Acute Otitis Media Therapeutics Market to Grow with a Moderate CAGR During 2021-2029; Increasing Prevalence of Acute Otitis Media to Drive the Market Growth

Research Nester released a report titled which delivers detailed overview of the global acute otitis media therapeutics market in terms of market segmentation by drug type, formulation, distribution channel...

BAYRY : 15.0100 (+0.07%)
NVS : 91.65 (+0.63%)
PDP.VN : 0.300 (+1.69%)
PFE : 41.75 (+0.68%)
NOVN : 8.36 (-2.90%)
LLY : 243.87 (+2.26%)
GSK : 39.55 (+0.82%)
MDP : 42.23 (+1.37%)
SAN : 3.69 (+1.93%)
ABT : 120.86 (+2.21%)
Banco Santander: Q1 Earnings Snapshot

MADRID (AP) _ Banco Santander SA (SAN) on Wednesday reported first-quarter net income of $1.94 billion.

SANW : 3.46 (+0.91%)
SAN : 3.69 (+1.93%)
Sanofi expands its social commitments, creates nonprofit unit to provide poorest countries with access to essential medicines

, /PRNewswire/ -- In an , Sanofi Chief Executive Officer today outlined several key projects that the company will implement to increase the impact of its Corporate Social Responsibility (CSR) strategy....

SAN : 3.69 (+1.93%)
SNY : 51.96 (+1.05%)
FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

, /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the treatment of adult patients with...

SAN : 3.69 (+1.93%)
SNY : 51.96 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Banco Santander SA is the biggest bank in Spain and the biggest international bank in Latin America as well. The Bank concentrates its activities in Andalucia, Castilla-Leon, Catalonia, Madrid, Valencia and Cantabria. The Bank provides banking services for individuals and companies, leasing, factoring,...

See More

Key Turning Points

3rd Resistance Point 3.75
2nd Resistance Point 3.73
1st Resistance Point 3.67
Last Price 3.69
1st Support Level 3.59
2nd Support Level 3.57
3rd Support Level 3.51

See More

52-Week High 4.38
Last Price 3.69
Fibonacci 61.8% 3.39
Fibonacci 50% 3.08
Fibonacci 38.2% 2.77
52-Week Low 1.78

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar